[{"id":"b57a2c09-5314-4526-80dc-a9991f983474","acronym":"","url":"https://clinicaltrials.gov/study/NCT04571138","created_at":"2021-01-18T21:49:43.303Z","updated_at":"2024-07-02T16:35:10.673Z","phase":"Phase 1/2","brief_title":"A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma","source_id_and_acronym":"NCT04571138","lead_sponsor":"Seattle Children's Hospital","biomarkers":" CD22","pipe":"","alterations":" ","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SCRI-CAR22v2"],"overall_status":"Recruiting","enrollment":" Enrollment 42","initiation":"Initiation: 09/25/2020","start_date":" 09/25/2020","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 02/01/2040","study_completion_date":" 02/01/2040","last_update_posted":"2024-04-09"}]